Skip to content

Evaluation of the effectiveness of telerehabilitation in patients with post COVID-19 condition

Evaluation of the effectiveness of telerehabilitation in patients with post COVID-19 condition - Mainz PCC TeR Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032394
Enrollment
80
Registered
2023-07-28
Start date
2023-07-31
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-/post-COVID-19 syndrome

Interventions

Group 1: The intervention group (TeR-INT) starts immediately (after randomization and stratification phase: 1 week after the medical and performance physiological initial examination: T0) with a syste
TAU). After 8 weeks and a midterm examination, the TeR-KG also receives a TeR and the TeR-INT receives a less close-meshed teletherapeutic care in an 8-week follow-up phase (instead of once a week, on

Sponsors

Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Voluntary participation Signature of the informed consent form Proven Covid-19 infection (PCR test and/or rapid antigen test provided by medical personnel). Diagnosed post-COVID syndrome

Exclusion criteria

Exclusion criteria: < 18 years No internet access and/or unable or unwilling to participate in the study Lack of capacity to give consent or doubts about capacity to give consent Participation in another rehabilitation program but this excludes individual medical services (such as psychotherapeutic therapy, GP visits). Red flags (Casser et al. 2016) and absolute contraindications to exercise and physical activity (American Thoracic Society 2003). Clinically significant 12-lead ECG abnormalities detected by the investigator and other symptoms (e.g., decreasing oxygen saturation) indicative of exercise intolerance Participation in another study Unable to perform a performance diagnostic test on a cycle ergometer Other unspecified reasons which, in the from the investigator's point of view speak against participation in the study

Design outcomes

Primary

MeasureTime frame
Both primary endpoints will be collected at all test time points (T0- Pre, T1- Post-INT, T2- Post Follow Up): - Maximum oxygen uptake [VO2peak (ml/min/kg)] - Regression quotient from minute ventilation and carbon dioxide production: VE/VCO2 slope [Full-Slope]

Secondary

MeasureTime frame
All secondary endpoints will be collected at all test time points (T0- Pre, T1- Post-INT, T2- Post Follow Up): - Submaximal and maximal exercise capacity (watts/kg) at ventilatory threshold 1 (VT1) and 2 (VT2) and at maximum oxygen uptake (VO2peak). - Respiratory economy: oxygen pulse, respiratory equivalent for carbon dioxide (ECO2) and end-tidal carbon dioxide content (PETCO2) at VT1 and VT2 and at end of exercise and Nijmegen Score (NQ Score) - The change in body shell temperature distribution in different body areas (ROI). - Inflammation [cytokines & cell-free genetic material (cfDNA)]. - Therapy adherence: number of training sessions performed (TE) / number of recommended TE - Patient Satisfaction - Post-exertional malaise (PEM questionnaire) - Somatization, depression and anxiety syndrome (Brief Symptom Inventory-18) - Severity of insomnia (Insomnia Severity Index) - Social support (Social Support Questionnaire Short Form) - Optimism and Pessimism (Optimism-Pessimism-2 Scale) - Self-efficacy (General Self-Efficacy Short Form Scale)

Countries

Germany

Contacts

Public ContactPerikles Simon

Institut für Sportwissenschaft

simonpe@uni-mainz.de+49 (0)6131 - 39 23 58

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 28, 2026